Mechanisms of homocysteine‐induced atherothrombosis
- 1 August 2005
- journal article
- review article
- Published by Wiley in Journal of Thrombosis and Haemostasis
- Vol. 3 (8), 1646-1654
- https://doi.org/10.1111/j.1538-7836.2005.01364.x
Abstract
Elevation of plasma homocysteine level is a risk factor for cardiovascular disease, stroke, and venous thromboembolism. It is still uncertain, however, whether hyperhomocysteinemia is a causative factor or a marker of vascular disease. The strongest evidence that homocysteine plays a causal role in atherothrombosis has been provided by studies using animal models. In the past decade, considerable progress in defining the vascular effects of hyperhomocysteinemia was achieved through the use of genetic and dietary approaches to induce hyperhomocysteinemia in experimental animals. A key vascular phenotype observed in hyperhomocysteinemic animals is endothelial dysfunction, manifested by decreased bioavailability of endothelium-derived nitric oxide. Impairment of endothelial function may be mediated by either accelerated oxidative inactivation of nitric oxide or inhibition of nitric oxide production caused by the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Hyperhomocysteinemia also increases susceptibility to arterial thrombosis and accelerates the development of atherosclerosis in susceptible models such as the apolipoprotein E-deficient mouse. Mechanisms of atherothrombosis may include homocysteine-induced thiolation or acylation of plasma or endothelial proteins and endoplasmic reticulum stress, which activates signal transduction pathways leading to inflammation and apoptosis.Keywords
This publication has 91 references indexed in Scilit:
- Homocysteine: is it a clinically important cardiovascular risk factor?Cleveland Clinic Journal of Medicine, 2004
- Folate Therapy and In-Stent Restenosis after Coronary StentingThe New England Journal of Medicine, 2004
- l-homocysteine and l-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cellsFree Radical Biology & Medicine, 2004
- HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Increased Superoxide Production in Coronary Arteries in HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Effect of hyperhomocysteinemia on protein C activation and activityBlood, 2002
- Vascular Outcome in Patients With Homocystinuria due to Cystathionine β-Synthase Deficiency Treated ChronicallyArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Homocysteine Induces Programmed Cell Death in Human Vascular Endothelial Cells through Activation of the Unfolded Protein ResponseOnline Journal of Public Health Informatics, 2001
- The asymmetrical dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in the regulation of nitric oxide generationClinical Science, 2001
- Dysfunction of Nitric Oxide Mediation in Isolated Rat Arterioles With Methionine Diet–Induced HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1999